Skye Bioscience, Inc. (SKYE)
1.18
-0.03
(-2.48%)
USD |
NASDAQ |
Dec 10, 15:40
Skye Bioscience Market Cap: 37.83M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 190.31M |
| Theravance Biopharma, Inc. | 892.85M |
| Viking Therapeutics, Inc. | 4.228B |
| FibroGen, Inc. | 35.87M |
| Myomo, Inc. | 41.51M |
Market Cap Related Metrics
| PEG Ratio | -0.0172 |
| Price to Book Value | 1.152 |
| Price | 1.18 |
| Earnings Yield | -109.3% |
| PEGY Ratio | -0.0172 |